Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma [clinicaltrials:NCT00042497]
Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma [clinicaltrials:NCT00042497]
Bio2RDF identifier
NCT00042497
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00042497
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The objective is to det ...... h Stage IV malignant melanoma
brief title [clinicaltrials_vocabulary:brief-title]
Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2002-07-30T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2005-06-23T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00042497
official title [clinicaltrials_vocabulary:official-title]
A Phase II, Multicenter, Open- ...... atients With Stage IV Melanoma
org study id [clinicaltrials_vocabulary:org-study-id]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2002-07-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2002-09-01T00:00:00Z
identifier
clinicaltrials:NCT00042497
title
Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma
@en
type
label
Immunotherapy With Autologous ...... a [clinicaltrials:NCT00042497]
@en